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Abstract
Implants made of commercially pure titanium (cpTi) are 
widely and successfully used in dentistry. For certain 
indications, diameter-reduced Ti alloy implants with 
improved mechanical strength are highly desirable. The aim 
was to compare the osseointegration of titanium-zirconium 
(TiZr) and cpTi implants with a modifi ed sandblasted and 
acid-etched (SLActive) surface and with a Ti6Al4V alloy 
that was sand-blasted and acid-washed. Cylindrical implants 
with two, 0.75 mm deep, circumferential grooves were 
placed in the maxilla of miniature pigs and allowed to heal 
for 1, 2, 4 and 8 weeks. Undecalcifi ed toluidine blue-stained 
ground sections were produced. Surface topography, area 
fraction of tissue components, and bone-to-implant contact 
(BIC) were determined. All materials showed signifi cantly 
different surface roughness parameters. The amount of 
new bone within the implant grooves increased over time, 
without signifi cant differences between materials. However, 
BIC values were signifi cantly related to the implant material 
and the healing period. For TiZr and cpTi implants, the BIC 
increased over time, reaching values of 59.38 % and 76.15 
% after 2 weeks, and 74.50 % and 84.67 % after 8 weeks, 
respectively. In contrast, the BIC for Ti6Al4V implants 
peaked with 42.29 % after 2 weeks followed by a decline to 
28.60 % at 8 weeks. Signifi cantly more surface was covered 
by multinucleated giant cells on Ti6Al4V implants after 4 
and 8 weeks. In conclusion, TiZr and cpTi implants showed 
faster osseointegration than Ti6Al4V implants. Both 
chemistry and surface topography might have infl uenced 
the results. The use of diameter-reduced TiZr implants 
in more challenging clinical situations warrants further 
documentation in long-term clinical studies.
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Introduction
In the last two decades, the surface topography of 
implants, mainly consisting of commercially pure titanium 
(cpTi), has been thoroughly investigated and markedly 
improved (Buser et al., 1998; Gotfredsen et al., 2000; 
Sul et al., 2002). Today, microrough cpTi implants 
dominate the market (Wennerberg and Albrektsson, 
2010), being produced with various techniques, such 
as sandblasting, acid-etching or combinations thereof. 
Significant enhancement of bone-to-implant contact 
(BIC) was found when the initial sand-blasted and acid-
etched cpTi surface (SLA) was made hydrophilic by 
chemical modifi cation (SLActive) (Buser et al., 2004). 
The SLActive cpTi surface is produced with the same 
sand-blasting and acid-etching procedure as for SLA, but 
rinsed under N2 protection and continuously stored in a 
NaCl solution (Steinemann and Simpson, 2004). However, 
placement of dental implants may be restricted by a lack 
of suffi cient bone volume at the implant site, requiring 
local bone augmentation. The utilisation of implants with 
a reduced diameter might avoid the necessity of local 
bone augmentation procedures. In comparison to the 
initial experiences with Ti grade 1, most of the implant 
systems today are made of much stronger Ti grade 4. Still, 
the mechanical properties of reduced-diameter grade 4 
Ti implants to withstand strong masticatory forces are 
diminished compared to standard-diameter implants 
(Rangert et al., 1995; Zinsli et al., 2004).
 In order to enhance its strength, Ti can be alloyed with 
other elements, such as aluminium (Al) and vanadium 
(V). About one third of all hip and knee replacements are 
successfully performed with Ti6Al4V, as demonstrated in 
a long-term study (Johnsen et al., 2006). Ti6Al4V alloy 
implants have not been recommended for cemented total 
hip arthroplasties, but are safe for anchorage without 
cement (Willert et al., 1996; Hinrichs et al., 2003). Since 
the early 1980s, the Ti6Al4V alloy has evolved to meet 
the needs in implant dentistry. Unfavourable results 
have been reported in dental applications, but they were 
mainly ascribed to the implant hollow screw design and 
unfavourable surface roughness (Malmqvist and Sennerby, 
1990). More recently, high survival and success rates for 
dental implants made of Ti6Al4V have been reported 
(De Leonardis et al., 1999; Bratu et al., 2009). Some 
experimental studies indicated significantly reduced 
removal torque values of Ti6Al4V when compared to 
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cpTi implants and less favourable bone response (Han et 
al., 1998; Johansson et al., 1998), whereas others did not 
indicate any signifi cant differences in bone response to 
both implant materials (Johansson et al., 1993).
 Ti alloys containing zirconium (Zr) show better tensile 
and fatigue strength than cpTi (Kobayashi et al., 1995; 
Ho et al., 2008). A titanium-zirconium (TiZr) alloy has 
recently been developed consisting of Ti alloyed with 
13-15 % Zr. The new binary material has a monophasic 
-structure which shows 13-42 % higher endurance level 
than cpTi, with the highest difference for 3.3 mm tissue 
level implants (Bernhard et al., 2009). Although the same 
surface modifi cations using sandblasting and acid-etching 
can be applied to cpTi (SLActive) and TiZr (SLActive) 
implants, it is possible that these two implant materials 
may end up with different surface characteristics (e.g., 
roughness, hydrophilicity and wettability). The physico-
chemical surface characteristics of Ti (SLActive) and 
TiZr (SLActive) implants might thus elicit different tissue 
responses. No signifi cant differences in BIC were found on 
Ti (SLActive) and TiZr (SLActive) within the grooves of 
cylindrical implants after 4 weeks of healing in miniature 
pigs (Gottlow et al., 2010) nor on standard screw-type Ti 
(SLActive) and TiZr (SLActive) dental implants after 2, 
4 and 8 weeks of healing in dogs (Thoma et al., 2011).
 The purpose of the present study was to examine the 
sequential healing and bone apposition to TiZr (SLActive) 
implants with a chemically modifi ed, hydrophilic implant 
surface up to 8 weeks in a standardised and demanding 
implant model with circumferential grooves (Buser et al., 
2004; Germanier et al., 2006). A chemically modifi ed, 
sandblasted and acid-etched Ti implant (SLActive) and 
another alloy, Ti6Al4V implant, with a sandblasted and 
acid-washed surface served as controls.
Materials and Methods
Implant design and surface characteristics
All experimental implants were cylindrical and had a length 
of 6 mm, a core diameter of 2.7 mm, and 3 rings with an 
outer diameter of 4.2 mm (Buser et al., 2004; Germanier 
et al., 2006). The two circumferential grooves had a depth 
of 0.75 mm and a height of 1.8 mm. The test and control 
implants were identical in shape, but differed in biomaterial 
composition and implant surface characteristics:
1. Test implant: TiZr implant with a 15 % zirconium 
content (-structure) and a sandblasted and acid-
etched chemically modified, hydrophilic surface 
(SLActive).
2. Control implant 1: Ti implant made of commercially 
pure titanium (cpTi) (grade 4) with a sandblasted and 
acid-etched chemically modifi ed, hydrophilic surface 
(SLActive).
3. Control implant 2: Ti6Al4V implant with a sand-blasted 
and acid-washed surface.
The test and control 1 implants had a standard SLActive 
surface sandblasted (corundum) with large grits measuring 
250-500 μm and then acid-etched in a boiling mixture 
of HCl and H2SO4. After acid-etching, the implants 
were further treated under nitrogen cover gas in order to 
prevent exposure to air. The implants were rinsed with 
pure water and fi nally stored in isotonic saline solution 
(Steinemann and Simpson, 2004). Although the surface 
of the test implant material was treated the same way as 
the control implant material 1, the characteristics of the 
two surfaces may differ because of the different materials 
used. The surface of the Ti6Al4V implants (control 2) 
was sandblasted in an identical way as the two other 
implant materials, followed by acid-washing (HNO3 65 
%) and water rinsing. Following surface treatment, all 
three implant materials were gamma sterilised. Surface 
topographies were qualitatively examined and compared on 
prefabricated discs of 5 mm in diameter made of the same 
material and surface treatment as test, control 1 and control 
2 implant materials using scanning electron microscopy 
(SEM). Surface topography was measured using confocal 
3D white light microscopy (μSurf, NanoFocus AG, 
Oberhausen, Germany) over an area of 798 μm x 798 μm. 
Three-dimensional roughness parameters Sa (arithmetic 
mean deviation of the surface), St (maximum peak-to-
valley height of the surface), Ssk (skewness of the surface) 
and a hybrid parameter Sdr (developed surface area) were 
calculated using a moving average Gaussian fi lter with a 
cut-off wavelength of 30 μm. Three measurements per 
sample and 3 samples per group were obtained (n = 9 
measurements).
Study design
A total of 12 adult (2-year-old) miniature female pigs were 
used in this study. The animals received standard food and 
water ad libitum. The protocol of the study was approved 
by the Committee for Animal Research, State of Bern, 
Switzerland (Approval No. 46/09), using a study design 
that has been successfully utilised in previous studies 
(Buser et al., 2004; Germanier et al., 2006).
Fig. 1. Longitudinal ground section showing the 
implant, peri-implant tissues, and the four implant 
grooves with marked region of interest.
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 Animals were premedicated using ketamine (i.m. 
20 mg/kg), xylazine (i.m. 2 mg/kg), atropine (i.v. 0.05 
mg/kg) and midazolam (i.v. 0.5 mg/kg) to achieve the 
intubation status. Inhalation anaesthesia was performed 
with isofl urane (1.0-15 %). Fentanyl patches (5-10 mcg/kg) 
were used for the intraoperative analgesia and the animals 
received antibiotic prophylaxis for three days (Duplocillin 
LA, 12000 U.I./kg).
 The anterior region of the maxilla was chosen 
according to our previous experience (Buser et al., 
2004; Germanier et al., 2006), allowing a simpler tooth 
extraction in comparison to the posterior maxilla. In total, 
three surgical interventions were performed per animal. 
In the fi rst surgery, all six incisors in the maxilla were 
removed and the sites were allowed to heal for at least 3 
months. Implants were placed during the second and third 
surgical interventions according to a split-mouth design. 
One implant per group (test, control 1 and control 2) was 
placed in one side of the maxilla using a systematic random 
protocol. In 6 animals, 3 to 4 implants were placed on 
the left side of the maxilla and one week later also on the 
right side of the maxilla. The animals were sacrifi ced one 
week later, yielding healing periods of 1 and 2 weeks. In 
the other 6 animals, 3 to 4 implants were placed on the 
left side of the maxilla and 4 weeks later also on the right 
side. The animals were sacrifi ced after 4 weeks, yielding 
healing periods of 4 and 8 weeks. A sample size consisted 
of 6 implants per experimental group and per time period 
(12 animals; n = 72 in total; n = 18 per time period; n = 6 
for each implant material). One bone block was harvested 
per side for each animal and the specimens chemically fi xed 
in 4 % formaldehyde solution supplemented with CaCl2.
Histological preparation and analysis
The specimens were rinsed in running tap water, 
dehydrated in ascending concentrations of alcohol, and 
embedded in methylmethacrylate (Schenk, 1984), as 
previously described (Buser et al., 1991; Cochran et 
al., 1998). Each implant was sectioned parallel to its 
longitudinal axis in the vestibulo-oral direction, resulting 
in three undecalcifi ed sections of about 500 μm thickness. 
The sections were ground to a fi nal thickness of 80 μm, 
superfi cially stained with toluidine blue (Schenk, 1984) 
and the two central-most sections were used for descriptive 
and morphometric analyses. The bone-to-implant contact 
(BIC) was determined for new bone matrix (osteoid, 
mineralised bone matrix) deposited along the surface of the 
implant grooves. The percentage of BIC was determined 
directly in the light microscope by intersection counting, 
using an integrative eyepiece with parallel sampling lines 
at a magnifi cation of x250 using a square grid (distance 
between test points = 40 μm at a magnifi cation of x250) 
(Weibel, 1979). In addition, the area fractions of soft tissue, 
osteoid and new mineralised bone within the area of the 
well-defi ned implant grooves were assessed by counting 
intersections using the same grid and magnification. 
Osteoid is the organic nonmineralised matrix of bone 
consisting of collagen and noncollagenous proteins. 
Osteoid in lamellar bone forms a thin matrix seam that 
is homogeneously eosinophilic and interposed between 
osteoblasts and mineralised bone matrix. Such a clear-cut 
distinction between mineralised bone matrix and osteoid 
cannot be made for woven bone. However, also during 
woven bone formation an equivalent to osteoid exists. 
Due to the structural nature of woven bone, the osteoid 
consists of thick randomly distributed collagen fi bres, 
which intermingle with nearby osteoblasts. Importantly, 
the osteoid of woven bone can clearly be distinguished 
from the soft tissue, rich in blood vessels, that fi lls the 
more central portion of neighbouring struts of woven 
bone. The region of interest was defi ned by the surface of 
the implant groove and the extension of the outer implant 
diameter (Fig. 1). The presence of multinucleated giant 
cells (MNGCs) on the implant surface within the grooves 
was determined for each implant material. The percentage 
of implant surface confi ned to the groove covered by these 
cells was calculated.
Statistical analysis
A two-tailed Student t-test (unequal variance) was used to 
compare differences in Sa, St, Ssk and Sdr between three 
different implant materials.
 The initial descriptive analysis of the data was done 
using scatter plots for the distribution of the analysed 
tissues (new osteoid, new mineralised bone, total new 
bone, and soft tissue) for BIC and bone volume (BV/TV) 
in the grooves analysed. To detect potential differences in 
the tissues for the three different implant materials tested 
for each time point, a Kruskal-Wallis test was performed 
for the BIC and BV/TV data sets separately. To analyse 
differences in the amount of hard and soft tissues over the 
four time points and the infl uence of the different implant 
materials, nonparametric analysis of variance (ANOVA) 
was used applying a Brunner-Langer model (Brunner et 
al., 2002).
 For the group comparison of implant surface fractions 
covered by MNGCs, we have used analysis of variance 
with Tukey postprocessing (SAS® PROC GLM). The 
signifi cance level chosen for all statistical tests was p ≤ 
0.05. Due to the small sample size and the explorative 
nature of this study, the p values were not adjusted for 
multiple testing. Therefore, statistically signifi cant fi ndings 
should be interpreted as trends. The ANOVA analyses were 
performed using a licensed software package (SAS 9.1, 
SAS Institute, Cary, NC, USA).
Results
Surface characterisation
Morphological differences in surface topography are 
shown in Fig. 2. Quantitative topographical analysis 
demonstrated statistically signifi cant differences between 
the three implant surfaces for all roughness parameters 
(p < 0.01), except for Sa between TiZr (SLActive) and 
Ti6Al4V (Table 1).
Histological and histomorphometric analysis
For all implant materials, bony ingrowth into the implant 
grooves and direct bone-to-implant contact (BIC) were 
evident already at 1 week of healing (Tables 2 and 3, Figs. 
3 and 4). While there was more osteoid than mineralised 
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bone present within the implant grooves at 1 week, the 
fraction of total new bone and the ratio between mineralised 
bone and osteoid steadily increased over time within the 
implant grooves (Table 2, Figs. 3-8). While the mean area 
fraction of bone in the implant grooves increased over 
time for all implant materials (Fig. 9), no statistically 
signifi cant differences were observed between implant 
materials (Table 4). Bone trabeculae fi rst consisted entirely 
of woven bone (Figs. 3-5) and were later reinforced by 
parallel-fi bered bone (Figs. 6-8). Mature bone marrow 
was not seen before week 8 (Figs. 3-8). Maturation of 
bone marrow adjacent to Ti6Al4V implants was less 
advanced than for TiZr (SLActive) and cpTi (SLActive) 
implants (Fig. 6). From week 4 to 8, many MNGCs 
were regularly observed on the surface of all Ti6Al4V 
implants (Figs. 6f and 8c). In contrast, almost no MNGCs 
were observed on TiZr (SLActive) or cpTi (SLActive) 
implants throughout the observation period (Figs. 8 and 
Table 1. Surface roughness parameters for the three implant types. Data are shown as means ± SD.
Implant 
type 
Arithmetic mean 
deviation of the surface 
(Sa, ìm) 
Maximum peak-to-
valley height of the 
surface (St, ìm) 
Skewness of the 
surface (Ssk) 
Developed surface 
area (Sdr, %) 
TiZr
cpTi 
Ti6Al4V 
1.299 ± 0.093
1.002 ± 0.020
1.333 ± 0.034 
8.90 ± 0.36
6.73 ± 0.18
9.49 ± 0.23 
0.211 ± 0.059
0.142 ± 0.032
-0.073 ± 0.031 
39.0 ± 3.3
29.6 ± 1.2
55.6 ± 2.3 
Table 2. Percentage of osteoid, mineralised bone, total new bone (osteoid and mineralised bone), 
and soft tissue over time in the area created by the implant grooves for the three implant materials. 
Data are shown as means ± SD.
Time 
point 
Implant 
material Osteoid 
Mineralised 
bone 
Total new 
bone Soft tissue 
Week 1 
TiZr
cpTi
Ti6Al4V 
11.73 ± 3.87
14.17 ± 5.74
15.10 ± 3.79 
0.74 ± 0.52
0.94 ± 1.24
1.08 ± 1.00 
12.48 ± 4.39 
15.11 ± 6.98 
16.17 ± 4.78 
86.24 ± 3.67 
84.20 ± 6.74 
83.33 ± 4.20 
Week 2 
TiZr
CpTi
Ti6Al4V 
16.75 ± 2.96
16.89 ± 3.90
13.28 ± 2.81 
20.47 ± 3.33
23.08 ± 3.52
18.14 ± 6.71 
37.22 ± 6.29 
39.97 ± 7.42 
31.42 ± 9.52 
60.64 ± 3.95 
58.72 ± 4.86 
66.12 ± 8.00 
Week 4 
TiZr
cpTi
Ti6Al4V 
16.49 ± 6.47
14.61 ±3.66
17.17 ± 6.47 
22.65 ± 6.47
22.23 ± 6.16
22.95 ± 7.07 
39.14 ± 6.47 
36.84 ± 9.82 
40.11 ± 13.53 
60.48 ± 6.47 
62.67 ± 5.83 
59.78 ± 2.49 
Week 8 
TiZr
cpTi
Ti6Al4V 
2.47 ± 0.79
1.93 ± 1.03
3.39 ± 2.16 
38.58 ± 7.31
35.80 ± 9.59
41.07 ± 11.59 
41.05 ± 8.10 
37.73 ± 10.62 
44.46 ± 13.76 
58.37 ± 8.53 
61.98 ± 9.85 
55.42 ± 12.74 
Statistically signifi cant differences are marked with the same letters (alpha level of 0.05).
Table 3. Percentage of osteoid, mineralised bone, total new bone (osteoid and mineralised bone), and soft tissue in 
contact with the surface along the grooves of the three implant materials over time. Data are shown as means ± SD.
Time 
point 
Implant 
type Osteoid Mineralised bone Total new bone Soft tissue 
Week 1 
TiZr 7.47 ± 4.33 1.72 ± 2.77 9.19 ± 7.10 90.46 ± 6.74 
cpTi 10.89 ± 5.97 2.73 ± 4.47 13.62 ± 10.44 86.26 ± 10.64 
Ti6Al4V 7.67 ± 5.05 1.47 ± 3.16 9.15 ± 8.21 90.14 ± 8.34 
Week 2 
TiZr 21.85 ± 6.84 37.53 ± 12.89 59.38 ± 19.73 40.31 ± 15.63 
cpTi 14.01 ± 5.31 62.14 ± 26.32 76.15 ± 31.62 23.52 ± 21.84 
Ti6Al4V 16.61 ± 10.70 25.68 ± 20.71 42.29 ± 31.41 57.62 ± 31.08 
Week 4 
TiZr 23.49 ± 8.03a 50.59 ± 8.42a 74.09 ± 16.45a 25.85 ± 7.58a 
cpTi
Ti6Al4V 
12.13 ± 5.39
6.43 ± 2.18a 
63.35 ± 12.30b
20.36 ± 10.69a,b 
75.48 ± 17.69b 
26.79 ± 12.87a,b 
24.53 ± 15.19b 
73.22 ± 10.28a,b 
Week 8 
TiZr 2.71 ± 1.60 71.80 ± 9.01a 74.50 ± 10.61a 25.48 ± 8.78a 
cpTi
Ti6Al4V 
1.48 ± 1.74
2.20 ± 1.35 
83.19 ± 10.88b
26.40 ± 30.17a,b 
84.67 ± 12.62b 
28.60 ± 31.52a,b 
15.32 ± 9.36b 
71.42 ± 30.90a,b 
Statistically signifi cant differences are marked with the same letters (alpha level of 0.05) 
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Fig. 2. Scanning electron microscope images showing the surface topographies of sandblasted and acid-etched (a, 
b) TiZr, (c, d) cpTi and sandblasted and acid-washed (e, f) Ti6Al4V surfaces.
10). The BIC steadily increased over time for both TiZr 
(SLActive) and cpTi (SLActive) implants, reaching values 
of 59.38 % and 76.15 % after 2 weeks, and 74.50 % and 
84.67 % after 8 weeks (Table 3, Fig. 10), respectively. 
The most pronounced increase in BIC occurred between 
week 1 and week 2. The development of the BIC on the 
Ti6Al4V surface showed a different pattern. After a peak 
of 42.29 % at 2 weeks, the BIC dropped to 28.60 % at 8 
weeks (Table 3, Fig. 10). The detailed statistical analysis 
including signifi cant differences for the BIC in relation 
to time, implant material and combined effect is shown 
in Table 5. The percentages of implant surface covered 
by MNGCs (mean, ± standard error) were as follows for 
TiZr, cpTi, and Ti6Al4V, respectively: 0.28 (± 0.21), 0.00 
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Fig. 3. Histological sections 
illustrating the implant grooves 
delineated by the implant surface 
and the bony wall of pristine bone 
at 1 (a, c, e) and 2 (b, d, f) weeks 
for all three implant materials. 
After 1 week, the blood coagulum 
(BC) is still present and most of 
the newly formed bone is osteoid 
(O). New mineralised bone (NB) is 
also present close to the cut bone, 
whereas little osteoid covers the 
implant surfaces. After 2 weeks, 
there is less blood coagulum, most 
of the newly formed bone matrix 
is mineralised, and the bone-to-
implant contact has signifi cantly 
increased from 1 to 2 weeks.
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(± 0.00), 2.26 (± 1.50) after 1 week, 1.19 (± 0.64), 3.23 
(± 3.23), 12.11 (± 5.18) after 2 weeks, 5.12 (± 1.79), 3.38 
(± 0.92), 42.61 (± 3.78) after 4 weeks, and 3.19 (± 0.77), 
0.42 (± 0.20), 54.37 (± 12.17) after 8 weeks (Fig. 10). The 
values for Ti6Al4V after 4 and 8 weeks were signifi cantly 
different from those obtained for TiZr and cpTi.
Discussion
The present experimental study examined the infl uence 
of the implant material on new bone formation using an 
implant model with circumferential grooves in miniature 
pigs. In contrast to the study of Gottlow et al. (2010), 
we examined the dynamics of bone healing by using 
four different healing periods. When compared with 
another animal study (Thoma et al., 2011), a much more 
demanding and better discriminating model has been used 
in the present study, since the implant grooves created a 
standardised defect gap of 750 μm. This defect gap is much 
larger than in the clinical situation. The present implant 
groove model is appropriate to study early bone healing 
events following implant placement, since the created 
defects are delineated on one side by the implant surface, 
and on the other side by the bony wall of the implant bed 
(Buser et al., 2004; Germanier et al., 2006).
 TiZr alloy has been recently introduced in the fi eld of 
implant dentistry for more challenging clinical situations, 
because it provides higher mechanical properties than 
cpTi grade 4 (Al-Nawas et al., 2011; Barter et al., 
2011; Chiapasco et al., 2011). Nevertheless, Ti6Al4V 
implants could also be used for small diameter dental 
implants because of improved mechanical strength when 
compared to cpTi and because of their favourable clinical 
documentation in orthopaedics (Bauer et al., 2009). 
All three implant surfaces used in the present study 
demonstrated moderate roughness values comparable to 
other contemporary implant systems (Wennerberg and 
Albrektsson, 2010). Concerning the amount of newly 
formed bone inside the implant grooves, no statistically 
significant differences were found between the three 
implant materials over time. The amount of new bone 
Fig. 4. Detailed histological 
views within the grooves facing 
the cut bone (a, c) and facing 
the TiZr implants (b, d). At 1 
week (a, b), the blood clot (BC) 
is clearly visible and osteoid 
(O) is seen connected to the cut 
old bone and deposited onto the 
implant surface. Arrowheads 
indicate initial mineralisation 
of osteoid. At 2 weeks (c, d), 
a dense network of trabecular 
bone is present, the ratio 
between mineralised bone (NB) 
and osteoid has increased, and 
developing primary osteons are 
seen (*).
280 www.ecmjournal.org
N Saulacic et al.                                                                          Osseointegration of titanium-zirconium alloy implants
formed within the grooves was only time-dependent, 
indicating a good healing potential in this animal model. 
The apposition of new bone onto the surface of the three 
examined implant materials, however, showed statistically 
signifi cant differences. Rather comparable values were 
found for the TiZr (SLActive) and cpTi (SLActive) 
implants. In contrast, the BIC values for Ti6Al4V implants 
remained signifi cantly lower from week 2 until the end of 
the observation period.
 The alteration in surface chemistry (i.e., SLActive) 
as compared to the standard SLA surface resulted in 
signifi cantly greater BIC at 2 and 4 weeks of healing in a 
miniature pig model (Buser et al., 2004) and recently at 
4 weeks in a human model (Lang et al., 2011). The BIC 
values in the present study for cpTi (SLActive) implants 
at 2, 4 and 8 weeks corroborate previous fi ndings (Buser 
et al., 2004; Gottlow et al., 2010). Increased oxygen on 
the hydrophilic titanium surface was attributed to the TiO2 
layer and increased hydroxylated/hydrated groups bound to 
the implant surface (Textor et al., 2001). Increased surface 
wettability affects the adsorption of inorganic matter (Ca 
and P) and molecules (proteins, lipoproteins and peptides) 
as well as the fi brin network from the blood onto the 
hydroxylated/hydrated groups of the SLActive surface, 
leading to a shortening of the healing period (Schwarz et 
al., 2009).
 In the present study, the peak BIC values throughout 
the healing period showed some delay for TiZr (SLActive) 
implants in comparison to cpTi (SLActive) implants, 
without reaching statistical signifi cance. It is presently not 
possible to know to which extent the material properties 
or the surface topography caused this slight difference. 
The surface of TiZr alloy is covered by a mixture of 
chemically inert TiO2 and ZrO2 (Chen et al., 2008). Due 
to its monophasic metal structure, TiZr can be treated 
like cpTi grade 4. Although the same surface treatment 
was applied to TiZr (SLActive) and cpTi (SLActive) 
implants in the present study, signifi cantly different surface 
roughness values were obtained. This implies that both 
surface roughness and surface chemistry may have caused 
the slight difference in the speed of bone apposition to the 
implant materials. The different biological profi le between 
TiZr and cpTi may be infl uenced by surface properties such 
as roughness, surface energy and substrate composition 
Fig. 5. Detailed histological views within 
the grooves at 2 weeks facing the cut bone 
(a) and facing the Ti6Al4V implants (b). A 
mineralised bone matrix (NB) is connected 
to the cut old bone and developing primary 
osteons are seen (*). Osteoid (O) is 
deposited onto the implant surface.
Table 5. Effect of time, implant material, and combined effects (time and material) on the 
amount of osteoid, mineralised bone, total new bone, and soft tissue deposited on the implant 
surface along the grooves of the three implant materials.
Effect Osteoid 
Mineralised 
bone Total new bone Soft tissue 
Time p = 0.0003 p < 0.0001 p = 0.0009 p = 0.0008 
Implant material p = 0.0250 p < 0.0001 p < 0.0001 p < 0.0001 
Combined p = 0.0074 p = 0.2506 p = 0.6115 p = 0.5737 
Effect Osteoid 
Mineralised 
bone
Total new 
bone Soft tissue 
Time p = 0.0002 p < 0.0001 p < 0.0001 p < 0.0001 
Implant material p = 0.9763 p = 0.9978 p = 0.9560 p = 0.9325 
Combined p = 0.2437 p = 0.1770 p = 0.4395 p = 0.4138 
Table 4. Effect of time, implant material and combined effects (time and material) on 
the amount of osteoid, mineralised bone, total new bone, and soft tissue in the area 
created by the implant grooves for the three implant materials.
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Fig. 6. Histological appearance 
within the implant grooves at 4 (a, c, 
e) and 8 (b, d, f) weeks for all three 
implant materials. The grooves 
of all three implant materials are 
filled with approximately the 
same amount of new bone (NB). 
Most of the newly formed bone 
matrix is mineralised and residual 
coagulum is still present. After 8 
weeks, bone is much more mature, 
as indicated by an increased ratio 
of mineralised bone to osteoid 
(O) and a higher maturity of 
bone marrow (BM). The bone-
to-implant contact is high for the 
cpTi and TiZr implant materials. 
However, the Ti6Al4V implants 
reveal markedly reduced bone-to-
implant contact, less mature bone 
marrow, and numerous MNGCs 
(arrows).
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(Sista et al., 2011). Minor differences in surface roughness 
(Ra < 0.50 μm) may directly regulate the percentage of 
cell adhesion and cytoskeletal organisation (Castellani 
et al., 1999). The percentage of initial attachment and 
proliferation of osteogenic cells was higher for TiZr alloy 
than for cpTi, with similar cell viability and spreading 
on both surfaces (Sista et al., 2011). Further in vitro data 
indicate that alkali and heat pre-treatment of cpTi, Zr 
and TiZr forms an apatite coating with a nanocrystalline 
microstructure, and that the speed of apatite formation 
appears to be related to the roughness value (Chen et al., 
2008). Following immersion in simulated body fl uid, a 
uniform and continuous apatite layer was formed on cpTi 
at 2 weeks and on Zr and TiZr at 3 weeks. This may be an 
explanation for the slight delay in bone apposition onto 
TiZr (SLActive) as opposed to cpTi (SLActive) implants, 
as observed in the present and in another study (Thoma et 
al., 2011).
 In the present study, rather similar values for BIC 
were found between TiZr (SLActive) and Ti (SLActive) 
implants at 4 and 8 weeks. The BIC value at 4 weeks for 
TiZr (SLActive) implants is comparable with that from 
another study in which the same implant groove model 
was used in miniature pigs (Gottlow et al., 2010). The BIC 
values for TiZr (SLActive) and cpTi (SLActive) implants 
in the present study at 4 and 8 weeks were signifi cantly 
Fig. 7. Detailed histological views of the TiZr (a), cpTi (b) and Ti6Al4V (c) implant materials. After 4 
weeks, the new bone consists of osteoid (O) and mineralised bone matrix (NB). A layer of new mineralised 
bone covers the implant surface.
Fig. 8. Detailed histological views of TiZr (a), cpTi (b) and Ti6Al4V (c) implant materials at 8 weeks. 
Both the newly formed bone matrix (NB) and bone marrow (BM) are mature. Note the presence of fatty 
marrow tissue. Numerous MNGCs (arrows) line the Ti6Al4V implants, the bone-to-implant contact is 
very low, and the scalloped bone surface indicates resorptive activity.
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Fig. 10. Histogram illustrating 
the effect of the implant materials 
on the percentage of bone-to-
implant contact (%BIC) and the 
percentage of implant surface 
along the grooves covered with 
MNGCs (%MNGCs) over time.
higher than those for Ti6Al4V implants. In other studies, 
a difference in BIC between Ti6Al4V and cpTi implants 
was also observed but did not reach statistical signifi cance 
(Han et al., 1998; Johansson et al., 1998). However, in the 
study by Han et al. (1998) blasting was performed with 
TiO2 particles with mean sizes of 25 μm in one group 
and 75 μm in another group, while the implants used by 
Johansson et al. (1998) were machined. In contrast, blasting 
with Al2O3 and acid-washing with 65 % HNO3 was used 
in the present study. Thus, these studies do not allow a 
direct comparison. Although the blasting material Al2O3 
is often embedded into the implant surface and may thus 
interfere with the osseointegration process, Le Guéhennec 
et al. (2007) and Wennerberg et al. (1996) could not fi nd 
statistically signifi cant differences in BIC values for cpTi 
implants blasted with Al2O3 or with TiO2 particles of the 
same size.
 Because of the biphasic nature of Ti6Al4V, sandblasting 
and acid-etching is typically not an appropriate treatment 
for α--alloys. The exposure of Ti6Al4V to the same 
acid-etching (mixture of HCl and H2SO4) as compared 
to TiZr (SLActive) and cpTi (SLActive) leads to an 
enrichment of the Vanadium-rich β-phase on the surface. 
Hence, sandblasting and acid-washing, which represents 
a much less aggressive surface treatment, was used in the 
present study for Ti6Al4V implant materials and resulted 
in a different surface topography (Fig. 3c). There are also 
conditions that preferentially etch the β-rich phase (e.g. 
with H2O2/H2SO4) (Variola et al., 2008).
 In the present study, numerous MNGCs were 
predominantly found on Ti6Al4V surfaces after 2, 4 and 8 
weeks (Fig. 10). In previous reports, similar observations 
were made in vitro with monocytes exposed to severed 
Ti6Al4V particles from retrieved orthopaedic implants 
(Bainbridge et al., 2001) and in vivo on implant surfaces 
made of Ti6Al4V and cpTi (Han et al., 1998; Johansson 
et al., 1998). These authors attributed the presence of 
MNGCs to the occurrence of small free metal particles 
Fig. 9. Histogram illustrating 
the increase in area fraction of 
total new bone (osteoid and 
mineralised bone matrix) (%NB) 
over time within the implant 
grooves of the three implant 
materials.
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(Han et al., 1998) or the release of metal ions (Johansson 
et al., 1998). However, in the present study no free metal 
particles adjacent to the surface of any implant material 
were found. The presence of MNGCs obviously lowered 
the osseointegration values of Ti6Al4V implants. However, 
the low short-term biocompatibility found in the present 
study for Ti6Al4V implants differs from other studies 
where Ti6Al4 after sandblasting with aluminium oxide and 
nitric acid passivation was neither cytotoxic nor genotoxic 
(Velasco-Ortega et al., 2010). In another study using the 
dorsal skinfold chamber model in hamsters a slight increase 
in leukocyte recruitment and a more sluggish recuperation 
of infl ammatory parameters was detected for Ti6Al4V 
when compared with cpTi (Pennekamp et al., 2006). 
Compared with stainless steel, the overall infl ammatory 
response to Ti6Al4V was very similar (Ryhänen et al., 
1998; Kapanen et al., 2001). Moreover, Ti6Al4V is 
considered as the material of choice for cementless implant 
materials in orthopaedics (Head et al., 1995) and successful 
clinical results were reported for Ti6Al4V dental implants 
that were machined and acid etched (De Leonardis et al., 
1999) and sand-blasted and acid-etched (Bratu et al., 2009). 
Taken together, it is clear that the surface treatment of metal 
implants is very critical for the osseointegration process 
(Le Guéhennec et al., 2007; Wennerberg and Albrektsson, 
2010). One plausible explanation for the low BIC and high 
surface coverage with MNGCs in the present study may 
be that sandblasting with Al2O3 followed by acid-washing 
with 65 % HNO3 created unfavourable material surface 
properties. Whether particle or ion release is also involved 
requires further studies. Furthermore, the small sample size 
and the explorative nature of the present study could be 
another confounding factor.
 In conclusion, the chemically modifi ed TiZr (SLActive) 
implant surface seems to have a similar potential for 
clinical applications as the clinically proven cpTi surface 
(SLActive). Based on the favourable mechanical properties 
and the fast osseointegration observed, the use of diameter-
reduced TiZr implants in more challenging clinical 
situations should be further examined in long-term clinical 
studies.
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Discussion with Reviewers
H. Plenk: Morphometry of bone-to-implant interfaces 
by grid counting: Of course, grids with appropriate line 
distances, corresponding to the microscopic magnifi cation 
as well as the orientation and distances of the bone 
structures have their value. However, particularly for the 
initial and spotty new bone deposition on implant surfaces, 
even an experienced observer will not perform properly, 
and may even be biased, while computerised evaluation 
of digital images is clearly superior.
Authors: We agree that computer-supported evaluation 
of digital images has undoubtedly its place in histometric 
evaluation of osseointegration. In recent years, we have 
compared classical grid counting technique with length or 
distance measurements on the computer screen. We would 
love to use such a computer-assisted program to measure 
the BIC. This is in most cases certainly a very appropriate 
technique, in particular for interface analysis of healed 
sites. However, in the case of bone matrix deposition onto 
an implant surface at a very early stage of healing, when 
tiny amounts of bone matrix are being deposited, we are 
still thoroughly convinced that the computer-assisted 
method is inferior to the grid counting technique and this 
for the following reasons: The grid counting technique 
can be performed directly in the microscope with the 
highest possible magnifi cation and resolution. This live 
image allows subtle focusing so that the interface between 
the implant and bone can always be optimally seen and 
therefore appropriately analysed. The disadvantage of 
this technique is that in case of very low BIC values, the 
given distance between adjacent lines in the grid may 
lead to inaccurate values. In contrast, length/distance 
measurements performed on the computer monitor do not 
have this disadvantage. However, the distinction between 
osteoid, mineralised new bone, bone debris particles (i.e., 
old bone), and soft tissue in contact with the implant surface 
has limitations due to a lower resolution and varying depths 
of focus. This is particularly the case at a very early stage of 
bone matrix deposition. In conclusion, we are thoroughly 
convinced that direct observation in the light microscope 
and the use of the grid counting technique is advantageous 
when it comes to investigating very initial bone matrix 
deposition onto metal or ceramic implants.
Reviewer II: What were the reasons for using Ti6Al4V as 
second control group?
Authors: This alloy has been chosen for two reasons: (a) it 
is a well-established Ti-alloy in orthopaedic implantology 
and (b) it has an increased mechanical strength when 
compared to cpTi, and similar mechanical qualities as the 
TiZr-alloy. Thus, it could as well be an alternative for small 
diameter dental implants.
Reviewer III: The ground sections were as thick as 80 
μm, which makes cellular details diffi cult to analyse. 
Please comment.
Authors: Our ground sections are indeed 80 μm in 
thickness. Most other histology laboratories use the Exakt 
System with a diamond-coated band saw where the ground 
sections are glued on transparent slides and ground down 
to 20-30 μm. Developed by Prof. Robert Schenk, one of 
the pioneers in the fi eld of osteosynthesis research, in 
our laboratory a low-speed Leco sawing machine with 
diamond-coated metal disks (wafers) is used, and instead 
of transparent mounting slides we use opalescent 1-2 
mm thick plastic plates to support the ground sections, 
combined with a surface stain technology. At fi rst sight, this 
may violate the rules of correct microscopic illumination, 
but in combination with the thick, surface stained sections 
it has a tremendous advantage that clearly outweighs the 
drawbacks resulting from neglecting the optical laws. The 
light passing through the opalescent slide and the surface-
stained section enable inspection of the very surface of the 
ground section with high resolution irrespective of section 
thickness. We could even use 200 μm thick sections with 
this technique without loss of resolution. Thus, there is 
actually no advantage of using thinner ground sections 
and there is no overestimation of the true bone-to-implant 
contact. Both qualitative and quantitative microscopy of 
our sample preparation technique are at least as good as 
with other techniques that use thinner sections.
H. Plenk: Toluidine blue is not a “metachromatic” stain, 
but stains cells and tissue ECM in different shades of 
“orthochromatic” blue(!), while only acidic proteoglycans, 
such as in the cartilage ECM, exhibit a metachromatic 
staining reaction in violet to red. This is due to the physico-
chemical position of the reactive groups in transmitted 
light. To solve the problem of distinction of osteoid from 
mineralised bone, the application of a counterstain, such as 
with Eosin in the Giemsa-solution, or with basic Fuchsin 
which Schenk used very successfully in many studies, 
would have allowed a clear differentiation of osteoid from 
mineralised early woven and mature lamellar bone.
Authors: When we were referring to the “metachromatic” 
properties of toluidine blue, we had, of course, the 
metachromatic staining properties of cartilage in mind. 
We fully agree that for the majority of tissues, toluidine 
blue behaves like an “orthochromatic” dye. We indeed 
apply the double staining technique of Prof. Schenk 
with toluidine blue and basic fuchsin in many ground 
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sections. However, we only apply this staining technique 
for the sake of producing beautiful images with a nice 
contrast between soft and hard tissues. When it comes to 
histomorphometric measurements, and particularly when 
osteoid needs to be distinguished from mineralised bone 
matrix, our experience is that the toluidine blue according 
to the method of McNeal is clearly superior to the above-
mentioned double staining. Therefore, we see no reason 
to switch to the double staining technique.
Reviewer IV: The authors defi ne osteoid as part of the 
bone tissue. Wouldn`t it be more fi tting to restrict this 
classifi cation to mineralised bone tissue alone and see 
osteoid as a parameter describing the formation dynamics?
Authors: If a material is more osteoconductive than 
another material, a difference in the amount of bone matrix 
deposited onto the material is expected to take place during 
the very early phases of healing. Indeed, several studies 
have shown that this is the case and that at later healing 
periods no signifi cant differences exist anymore. Osteoid 
was determined in both of these two situations. Also osteoid 
at the leading (building) front of woven bone formation was 
considered, although not as clearly visible as in the case 
of later stages of bone apposition. Particular attention was 
paid to distinguish between tissue that develops into woven 
bone and non-osteogenic soft tissue. Criteria to distinguish 
between these two situations include: size and shape of 
cells, structure and density of the collagenous extracellular 
matrix, and number and distribution of blood vessels.
Reviewer II: It is doubtful that the general public is 
aware of the existence of osteoid laid down for woven 
bone production. As the larger part of your measured 
osteoid appears to be of that type, again for the sake of 
reproducibility, the readers should be made aware of this 
fact. If somebody would try to reproduce the study and 
only measured “lamellar bone osteoid” the results would 
be completely different.
Authors: We agree that the “osteoid” of woven bone is not 
comparable to the osteoid of parallel-fi bered or lamellar 
bone. Since this is a critical aspect and not many people 
are aware of this difference we have added the following 
sentence in the M&M section: “Osteoid is the organic 
nonmineralised matrix of bone consisting of collagen and 
noncollagenous proteins.” Osteoid in lamellar bone forms 
a thin matrix seam that is homogeneously eosinophilic 
and interposed between osteoblasts and mineralised bone 
matrix. Such a clear-cut distinction between mineralised 
bone matrix and osteoid cannot be made for woven bone. 
However, also during woven bone formation an equivalent 
to osteoid exists. Due to the structural nature of woven 
bone, the osteoid consists of thick randomly distributed 
collagen fi bres, which intermingle with nearby osteoblasts. 
Importantly, the osteoid of woven bone can clearly be 
distinguished from the soft tissue, rich in blood vessels, 
that fi lls the more central portion of neighbouring struts 
of woven bone.
Reviewer I: Why do the dimensions of the “chamber” 
of the TiZr-implant at 1 week in Fig. 3 look so different 
from all other chambers, if the images have the same 
magnifi cation? Were the grooves (or the “circular rings”) 
on the cylindrical implants not all of the same size?
Authors: It is impossible that all grooves look the same. 
Not every middle section is precisely going through the 
real centre of an implant. Sometimes, a section is right in 
the centre, sometimes slightly off-centre. Therefore, the 
depths of the grooves vary.
Reviewer I: No TRAP staining was done. Please comment.
Authors: TRAP is believed to be specifi c for osteoclasts/
odontoclasts. Osteoclasts are large, usually multinucleated 
cells with a ruffl ed border and a sealing zone, expressing 
a variety of molecules including TRAP, RANK, c-Fms, 
VNR, CTR, CD68 etc. In the present study, we are dealing 
with large, multinucleated cells adhering on metal surfaces. 
These cells cannot be regarded as osteoclasts. They rather 
are foreign body cells. Thus, the use of a cell marker for 
foreign body cells would be much more appropriate. 
Unfortunately, the application of cell markers in tissues 
embedded in MMA is very restricted because of masking 
and antigen destruction due to heat production during 
polymerisation. Based on the striking observation of 
many MNGCs on the TAV implants treated with HCl and 
H2SO4 after sandblasting, future investigations may use 
other models and techniques to detect markers associated 
with MNGCs.
Reviewer II: The formation of bone in cancellous areas is 
certainly faster than in cortical ones. But is the total and 
relative amount of newly formed bone tissue not eventually 
higher in cortical regions? That at least is my experience. 
Please comment!
Authors: Your are right, once bone formation is established 
and remodelling sets in, it can be anticipated that the “bone 
density” is higher in cortical bone than in cancellous bone, 
provided that compact bone persists at such a site.
Reviewer II: How far is the minipig model transferable 
to the human situation?
Authors: Within a specifi c fi eld of research, no single 
animal model might be ideal to answer all purposes. 
Minipigs are large and skeletally mature animals that 
mimic the bone biology of humans better than rodents, 
which have a much faster metabolism and remodelling 
rate and are thus less suitable to represent a typical clinical 
situation. Minipigs are reported as a suitable model for a 
variety of research topics including bone fractures (Pearce 
et al., 2007, additional reference), bone grafting materials 
(Jensen et al., 2011, additional reference) and dental 
implants (Buser et al., 2004, text reference). Furthermore, 
a recent study in humans (Lang et al., 2011, text reference) 
showed that the same difference between cpTi implants 
with SLA and SLActive surfaces was found as in minipigs 
(Buser et al., 2004, text reference). Thus, the minipig for 
bone research appears to be close to the human situation 
and avoids the use of non-human primates, which are 
always associated with ethical concerns an substantially 
elevated research costs (Muschler et al., 2010, additional 
reference).
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Reviewer III: The TiAl4V surfaces were not chemically-
activated (SLActive). Could authors comment on the 
effect of such activation on the overall performance of 
the surfaces?
Authors: The main differences of the chemically modifi ed 
SLA surface (SLActive) compared to the non-activated 
SLA are the following: The activation leads to a low level 
of carbon contamination and thus to a hydrophilic surface 
with a high surface energy, whereas non-activated surfaces 
present a higher level of carbon contamination resulting in 
hydrophobic surfaces (low surface energy). It is believed 
that the hydrophilicity is highly benefi cial for the formation 
of the fi brin network and for the stabilisation of the blood 
clot. Therefore, the modifi ed surface is benefi cial at an 
early stage of the healing phase and accelerates the whole 
healing process (Hong et al., 2011, additional reference). 
Furthermore, in a similar implant model as in the present 
study, signifi cantly enhanced bone apposition was found 
on Ti implants with SLActive treatment compared to Ti 
implants with SLA treatment (Buser et al., 2004, text 
reference). To the best of our knowledge, we do not know 
what the effect of such an implant surface modifi cation may 
be on a sandblasted and HCl and H2SO4 treated Ti6Al4V 
material.
Reviewer III: Please discuss the differences between TiO2 
and Al2O3 used as blasting materials.
Authors: In addition to the potential risk of Al ion 
dissolution from the blasting material into the host tissue, 
the histomorphometrical analysis of implants blasted with 
Al2O and TiO2 particles of the same size demonstrated 
no signifi cant differences (Wennerberg et al., 1996, text 
reference). However, a potential difference might be 
expected when sandblasting occurs on a different implant 
material, since the release of Al ions from Ti6Al4V 
implants blasted with Al2O3 particles coincided with lower 
values of removal torque and bone-to-implant contact in 
comparison with cpTi implants (Johansson et al., 1992, 
additional reference). It is also possible, that the Al2O3 
particles are not more toxic than TiO2 particles. Actually, 
TiO2 particles might even provoke a signifi cantly higher 
TNFα response than Al2O3 particles of the same size 
(Sterner et al., 2004, additional reference). The inhibition 
of cell proliferation by Al2O3 and TiO2 particles is very 
low, which makes diffi cult to detect small differences in 
their toxic behaviour (Yamamoto et al., 2004, additional 
reference). The different tissue responses to the two 
types of particles might thus be explained by geometrical 
factors, i.e. their size, shape and structure. As previously 
reported, the attenuation of osteoblast function depends 
on the size of Ti particles; different mechanism may be 
elicited by Ti particles of different sizes (Choi et al., 2005, 
additional reference). Considering cell cytotoxicity of TiO2 
particles in different shapes, the dendritic particles had the 
strongest effect followed by spindle and spherical shapes 
(Yamamoto et al., 2004, additional reference). These results 
suggest that the number of sharp edges is important for 
cytotoxicity, since the fi brous shape was more cytotoxic 
than the spherical shape.
Reviewer I: If future researches are in the horizon, are 
authors planning to use comprehensive, possibly non-
destructive methods to quantitate and compare bone 
formation at the implant interface?
Authors: In order to evaluate the rate of osseointegration 
over time for new implant materials/surface treatments, 
we will continue to use morphometric measurements 
performed in ground sections and this for the following 
two reasons: (1) This reliable technique allows comparison 
with data from other studies where the same technique 
was applied, and (2) Although for example micro-CT is 
a non-destructive method that allows quantifi cation of 
bone volume and other parameters with nowadays also 
high resolution, the vicinity to a metal implant generates 
aberrations. The bone-to-implant contact measurements 
have to be performed at the metal-bone interface. The bone 
at this interface is extremely thin, particularly after 1 week 
of healing, and can therefore not accurately be determined 
by any radiographic technique available today.
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